Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 30-Sep 2021. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3762834018 | Erythromycin 20 microgram/mg cutaneous ointment | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3762835017 | Product containing precisely erythromycin 20 microgram/1 milligram conventional release cutaneous ointment (clinical drug) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing precisely erythromycin 20 microgram/1 milligram conventional release cutaneous ointment (clinical drug) | Is a | Product containing erythromycin (medicinal product) | false | Inferred relationship | Some | ||
| Product containing precisely erythromycin 20 microgram/1 milligram conventional release cutaneous ointment (clinical drug) | Is a | Product containing erythromycin in topical dosage form | false | Inferred relationship | Some | ||
| Product containing precisely erythromycin 20 microgram/1 milligram conventional release cutaneous ointment (clinical drug) | Has active ingredient | Erythromycin (substance) | false | Inferred relationship | Some | ||
| Product containing precisely erythromycin 20 microgram/1 milligram conventional release cutaneous ointment (clinical drug) | Has active ingredient | Bactericide | false | Inferred relationship | Some | ||
| Product containing precisely erythromycin 20 microgram/1 milligram conventional release cutaneous ointment (clinical drug) | Has manufactured dose form | Cutaneous AND/OR transdermal dosage form | false | Inferred relationship | Some | ||
| Product containing precisely erythromycin 20 microgram/1 milligram conventional release cutaneous ointment (clinical drug) | Has manufactured dose form | Cutaneous ointment | false | Inferred relationship | Some | ||
| Product containing precisely erythromycin 20 microgram/1 milligram conventional release cutaneous ointment (clinical drug) | Is a | TEMPORARY parent for CDs that are not updated | false | Inferred relationship | Some | ||
| Product containing precisely erythromycin 20 microgram/1 milligram conventional release cutaneous ointment (clinical drug) | Count of base of active ingredient | 1 (kwalificatiewaarde) | false | Inferred relationship | Some | ||
| Product containing precisely erythromycin 20 microgram/1 milligram conventional release cutaneous ointment (clinical drug) | Has concentration strength numerator value | 20 (kwalificatiewaarde) | false | Inferred relationship | Some | 1 | |
| Product containing precisely erythromycin 20 microgram/1 milligram conventional release cutaneous ointment (clinical drug) | Is a | Product containing only erythromycin in cutaneous dose form (medicinal product form) | false | Inferred relationship | Some | ||
| Product containing precisely erythromycin 20 microgram/1 milligram conventional release cutaneous ointment (clinical drug) | Has basis of strength substance (attribute) | Erythromycin (substance) | false | Inferred relationship | Some | 1 | |
| Product containing precisely erythromycin 20 microgram/1 milligram conventional release cutaneous ointment (clinical drug) | Has concentration strength denominator unit | mg | false | Inferred relationship | Some | 1 | |
| Product containing precisely erythromycin 20 microgram/1 milligram conventional release cutaneous ointment (clinical drug) | Has concentration strength numerator unit | mcg | false | Inferred relationship | Some | 1 | |
| Product containing precisely erythromycin 20 microgram/1 milligram conventional release cutaneous ointment (clinical drug) | Has concentration strength denominator value | 1 (kwalificatiewaarde) | false | Inferred relationship | Some | 1 | |
| Product containing precisely erythromycin 20 microgram/1 milligram conventional release cutaneous ointment (clinical drug) | Has precise active ingredient | Erythromycin (substance) | false | Inferred relationship | Some | 1 | |
| Product containing precisely erythromycin 20 microgram/1 milligram conventional release cutaneous ointment (clinical drug) | Plays role | Antibacterial therapeutic role (role) | false | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Reference Sets
Concept inactivation indicator reference set
SAME AS association reference set (foundation metadata concept)
FHIR